Efficacy of tenofovir disoproxil fumarate switch therapy in chronic hepatitis B patients with suboptimal response to adefovir-based combination therapy

In the present study, the efficacy and safety of tenofovir disoproxil fumarate (TDF) switch therapy were assessed in patients with chronic hepatitis B exhibiting a suboptimal response to adefovir (ADV)-based combination therapy. First, the efficacy of the TDF switch therapy was retrospectively evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiangyong, Luo, Jie, Zhu, Changhao, Wu, Yuankai, Li, Zhanyi, Jie, Yusheng, Zhang, Yeqiong, Lin, Guoli, Li, Xinhua, Zhang, Ying, Shu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327499/
https://www.ncbi.nlm.nih.gov/pubmed/30679993
http://dx.doi.org/10.3892/etm.2018.7081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327499/
https://www.ncbi.nlm.nih.gov/pubmed/30679993
http://dx.doi.org/10.3892/etm.2018.7081

Ejemplares similares